Manufacturer's Monthly

JUNE 5, 2023

Vaxxas announced positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate delivered using its proprietary high-density microarray patch (HD-MAP) technology. The post Clinical results of Vaxxas needle free vaccine technology appeared first on Manufacturers' Monthly.

Manufacturing 98

Manufacturing 98

Canadian Metalworking Magazine

OCTOBER 6, 2022

Our new ‘ Regulatory Changes ’ Machine Learning model allows you to: Track the new laws that are affecting your market Monitor the regulations that are affecting new technologies Keep up with any regulatory and clinical trial developments in the biopharma industry. START 30-DAY FREE TRIAL. Start 30-day free trial.

116

116

AU Manufacturing

NOVEMBER 3, 2022

GPN Vaccines , a South Australian biotech company, has successfully developed a new universal vaccine that targets a pneumonia-causing bacterium. . Giorgio said the vaccine’s successful development has been underpinned by access to cutting-edge research, development, and manufacturing facilities in Adelaide. .

Manufacturing 91

Manufacturing 91

Frost & Sullivan Manufacturing

JANUARY 30, 2023

Novotech has more than 2,500 team members providing end-to-end clinical development support to more than 600 biotechnology clients covering all clinical trial phases in APAC, Europe, and North America.

52

52

Frost & Sullivan Manufacturing

MAY 3, 2023

. – 4 th May 2023 – Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes George Clinical with the 2023 Asia-Pacific Competitive Strategy Leadership Award. George Clinical provides a human touch to its projects, ensuring quality outcomes for clients and patients.

52

52

Manufacturer's Monthly

DECEMBER 7, 2023

Biotechnology company BioNTech is planning to develop and commission a state-of-the-art mRNA clinical-scale manufacturing facility at the La Trobe Melbourne campus in Bundoora. The Centre will sit alongside the planned BioNTech facility.

Manufacturing 98

Manufacturing 98

AU Manufacturing

JUNE 18, 2023

Launching Vaxxas ’ new facility marks another milestone in the Northshore Hamilton Priority Development Area’s transformation. Economic Development Queensland worked closely with Vaxxas to progress designs and approval for this facility, so it’s fantastic to be here to open it.”

Manufacturing 87

Manufacturing Advanced manufacturing 87

Canadian Manufacturing

SEPTEMBER 16, 2022

says it is currently evaluating the oral use of psilocybin to help treat methamphetamine use disorder with the University of Wisconsin-Madison, and it has also initiated a product development program under a feasibility agreement with LTS Lohmann Therapie-Systeme AG for the development of a Psilocybin thin film strip product. “We

Prototype  98

Prototype  Manufacturing Pharmaceutical 98

Manufacturer's Monthly

JUNE 18, 2023

The custom-built 5,500m square-metre (60,000 square feet) Vaxxas Biomedical Facility is a first-of-its-kind manufacturing site designed to support the scale-up of Vaxxas’ needle-free vaccine technology platform, the high-density microarray patch (HD-MAP), for late-stage clinical trials and first commercial products.

Manufacturing 105

Manufacturing 105

Manufacturer's Monthly

AUGUST 10, 2022

Researchers at CSIRO’s National Vaccine and Therapeutics Lab will turn vaccine and drug candidates into products that can be manufactured in large quantities for clinical trials. The CSIRO has opened a new $23.1 million national lab in Melbourne that will bolster Australia’s ability to produce vaccines and drug treatments onshore.

Manufacturing 98

Manufacturing Advanced manufacturing 98

Frost & Sullivan Manufacturing

DECEMBER 19, 2023

San Antonio, TX — December 19, 2023 — Frost & Sullivan today recognized Parexel , one of the world’s largest clinical research organizations (CROs), with the 2023 North American Customer Value Leadership Award following recent in-depth research of the Real-world Evidence (RWE) services industry.

Electronics 52

Electronics Function Sourcing 52

AU Manufacturing

AUGUST 10, 2022

The development of the facility was supported with funding of $1.1 What started with a business plan, lab design and purchase of equipment has led to the opening of a facility of national importance for Australia’s biomedical efforts and our clinical trials industry,” he said.

Manufacturing 91

Manufacturing Advanced manufacturing 91

Manufacturer's Monthly

OCTOBER 6, 2022

The Victorian state government has agreed to an in-principle partnership with leading German biotechnology company BioNTech to establish a clinical-scale mRNA manufacturing facility in the state. The partnership was announced today by treasurer Tim Pallas and minister for innovation, medical research and the digital economy Jaala Pulford.

Manufacturing 119

Manufacturing Artificial Intelligence Pharmaceutical Advanced manufacturing 119

AU Manufacturing

AUGUST 10, 2022

Researchers at CSIRO’s National Vaccine and Therapeutics Lab will turn vaccine and drug candidates into products that can be manufactured in large quantities for clinical trials. CSIRO, Australia’s national science agency, has opened a new $23.1 Companies interested in working with the new facility should contact 1300 363 400.

Advanced manufacturing 86

Advanced manufacturing Manufacturing 86

Canadian Manufacturing

NOVEMBER 29, 2023

The Vancouver-based company that helped develop the first antibody therapy treatment for COVID-19 has announced layoffs amounting to 10 per cent of its workforce. The filing says the layoffs and reorganization will help it “focus its efforts toward the clinical development of new antibody medicines for patients.”

Manufacturing 52

Manufacturing Compliance 52

Canadian Manufacturing

MARCH 19, 2024

a clinical-stage oncology company focused on developing radioconjugates (RCs) as precision medicines, announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. FPI-2265 targets prostate-specific membrane antigen (PSMA), a protein that is highly expressed in mCRPC, and is currently in a Phase 2 trial.

Pharmaceutical 52

Pharmaceutical Supply Chain Manufacturing Advanced manufacturing 52

Additive Manufacturing

AUGUST 6, 2022

Leipzig, Germany, August 4, 2022 – BellaSeno GmbH announced the start of two clinical trials of its resorbable scaffolds using additive manufacturing technologies in Australia. The second trial aims to enroll 20 patients who either need breast implant revision or surgery to correct congenital breast defects.

3D printing 94

3D printing Additive manufacturing Form Manufacturing 94

E&T

DECEMBER 22, 2022

The centre, which will be able to produce up to 250 million vaccines a year, will see the UK Health Security Agency (UKHSA) working with Moderna to ensure early vaccine development, supporting the G7 mission to get from variant to vaccine in 100 days.

Manufacturing 111

Manufacturing 111

Manufacturer's Monthly

APRIL 18, 2023

Contract development and manufacturing organisation (CDMO) PCI Pharma Services (PCI) announced the operational launch of three new state-of-the-art automated sterile fill-finish machines at its Melbourne and San Diego facilities. “As

Manufacturing 98

Manufacturing Pharmaceutical Compliance Automation 98

Additive Manufacturing

NOVEMBER 30, 2022

“We are excited to receive IND clearance to begin clinical trials of this potentially transformative treatment for patients, ” said Dr. Senping Cheng, founder and CEO of Triastek. We look forward to advancing this treatment into the clinic and appreciate the FDA’s support. NANJING, China, Nov.

3D printing 98

3D printing Form Pharmaceutical Additive manufacturing 98

Frost & Sullivan Manufacturing

DECEMBER 8, 2022

San Antonio, TX — December 8, 2022 — Based on its recent analysis of the clinical trial patient recruitment IT solutions industry, Frost & Sullivan recognizes TrialWire with the 2022 Global Clinical Trial Patient Recruitment IT Solutions Technology Innovation Leadership Award.

Artificial Intelligence 52

Artificial Intelligence Function 52

Additive Manufacturing

AUGUST 8, 2022

The medical community also saw progress toward true bioprinting with the announcement of clinical trials in Australia of two 3D biofabricated implants. The post Energy, Clinical Trials, Executives & Other News for Week of August 1 appeared first on Additive Manufacturing (AM).

3D printing 98

3D printing Prototype  Additive manufacturing Composites 98

E&T

JULY 7, 2023

Developed in the 1960s, it is the first ever bionic device created to restore a sensory organ and has now been fitted in over a million people. One such study is a first-in-human clinical trial, conducted by four Australian universities, to use gene augmentation therapy to improve hearing outcomes in cochlear implant patients.

Pharmaceutical 111

Pharmaceutical Bottleneck Fit Electronics 111

Canadian Manufacturing

MAY 25, 2023

A Vancouver-based company that helped develop the first antibody therapy treatment for COVID-19 is expanding its research and development capacity as it continues to pursue world-leading new medicines, says Innovation Minister Francois-Philippe Champagne. “It means access to frontline treatment through clinical trials. .

Manufacturing 40

Manufacturing Pharmaceutical 40

Manufacturer's Monthly

DECEMBER 11, 2022

Biotechnology company Vaxxas has raised US$23 million (A$34 million) in financing to progress multiple clinical programs, including the company’s needle-free COVID-19 vaccine candidate and ramp up manufacturing capabilities toward commercial scale.

Manufacturing 98

Manufacturing 98

Frost & Sullivan Manufacturing

APRIL 25, 2023

Emmes is a full-service, global Clinical Research Organization (CRO) committed to promoting public health and biopharmaceutical innovation. The company brings a solid statistical approach to every clinical study phase, such as protocol development, statistical analysis, and publishing.

Pharmaceutical 52

Pharmaceutical 52

AU Manufacturing

OCTOBER 6, 2022

German biotechnology manufacturer BioNTech has selected Victoria to house its Asia-Pacific mRNA clinical research and development centre. . Victoria and BioNTech have entered formal discussions to bring the company’s cutting-edge solutions into the state by establishing a clinical-scale mRNA manufacturing facility in Melbourne. .

Pharmaceutical 94

Pharmaceutical Artificial Intelligence Manufacturing 94

Manufacturer's Monthly

JUNE 8, 2023

The Australian Research Council (ARC) acting chief executive officer, Dr Richard Johnson, officially launched the ARC Research Hub for Digital Bioprocess Development in Melbourne.

Artificial Intelligence 98

Artificial Intelligence Manufacturing Value chain 98

Canadian Manufacturing

JANUARY 13, 2023

a company accelerating the development, and global access to radiopharmaceuticals, announced the completion of enrollment for the randomization phase in the pivotal phase 3 SPLASH trial, on schedule and meeting previous guidance. For PNT2003, POINT recently received the OZM-067 clinical trial data sets from the trial sponsor.

Form 40

Form Function Manufacturing 40

Frost & Sullivan Manufacturing

FEBRUARY 15, 2023

The company’s consultative approach and cutting-edge AI are changing biomarker analysis to enhance drug development and diagnostics. Flagship’s virtual pathology offering aligns with decentralized clinical trials, a growing trend. It offers clinically-validated solutions for clinical research applications.

Artificial Intelligence 52

Artificial Intelligence 52

AU Manufacturing

FEBRUARY 11, 2023

Vaxxas , a biotechnology company commercialising a novel vaccination platform, has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.

Logistics 52

Logistics Manufacturing 52

Manufacturer's Monthly

AUGUST 15, 2023

The new headquarters provides a base of operations for Moderna to partner with Victoria’s world-leading medical research institutes and clinical trial networks, ensuring Victorians will be some of the first people in the world to trial new mRNA medicines for a range of health conditions.

Pharmaceutical 98

Pharmaceutical Advanced manufacturing Manufacturing 98

Frost & Sullivan Manufacturing

JANUARY 11, 2023

Verana Health’s VeraQⓇ population health data engine transforms structured and unstructured EHR data into curated, quality data (QdataⓇ) to power insights on care quality, treatment patterns and outcomes, clinical trial site selection, therapeutic market share, and more.

Artificial Intelligence 52

Artificial Intelligence Fit Electronics Sourcing 52

AU Manufacturing

DECEMBER 6, 2022

Vaxxas , a clinical-stage biotechnology company commercializing a novel vaccination platform, has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds. Media Release by Vaxxas. This investment round was led by existing investors OneVentures and UniQuest Pty Ltd. About Vaxxas.

Manufacturing 88

Manufacturing 88

Manufacturer's Monthly

SEPTEMBER 17, 2023

Moderna is also forming partnerships with Victoria’s world-leading medical research institutes and clinical trial networks, allowing Victorians to be among the first people in the world to trial new mRNA medicines for a range of health conditions. million in the 2023/24 budget to develop mRNA technology and builds on the $1.3

Advanced manufacturing 98

Advanced manufacturing Pharmaceutical Form Manufacturing 98

AU Manufacturing

SEPTEMBER 22, 2022

Sydney-based radiopharmaceutical company AdvanCell has received the 2022 Australian Good Design Award of the Year for its world-first Alpha Isotope Generator designed by leading Australian product development consultancy, Design + Industry (D+I). . AdvanCell is an Australian company dedicated to changing the course of cancer treatment.

Sourcing 91

Sourcing Supply Chain Electronics Pharmaceutical 91

Additive Manufacturing

JANUARY 21, 2023

The RegenMed Development Organization (ReMDO) and the Wake Forest Institute for Regenerative Medicine (WFIRM) are two organizations accelerating the discovery and translation of regenerative medicine therapies. Epredia is a global distribution partner for Aiforia’s portfolio of preclinical and clinical pathology tools.

Artificial Intelligence 52

Artificial Intelligence Prototype  Form Additive manufacturing 52